Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at Stephens Investment Conference (Virtual) Transcript

Dec 03, 2021 / 03:00PM GMT
Release Date Price: €119 (-3.25%)
Scott J. Fidel
Stephens Inc., Research Division - MD & Analyst

Okay. Well, welcome back to the Stephens Investment Conference live and in person in Nashville. I'm Scott Fidel, I'm the health care services analyst. We're delighted to have Amedisys here joining us for our next fireside chat panel. Amedisys is one of the leading operators of home-based home health, hospice and other growing areas of the business and the home side. So we've got the full team here today. We've got Paul Kusserow, the Chairman and CEO; Scott Ginn, who is the Chief Financial Officer; Nick Muscato, who heads up finance -- SVP of Finance, Investor Relations. And then really pleased to have a special guest with us today as well, Travis Messina, who is the CEO of Contessa, which Amedisys has just recently acquired and it's going to be a new growth platform on the Amedisys chassis. So looking forward to the conversation. Guys, thanks so much for joining us today. It's great to see you all in person especially.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman & CEO

Good to be here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot